The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery
Abstract
α-Mangostin-loaded mucoadhesive nanoparticles (NPs) were prepared for colon-targeted drug delivery against colorectal cancer cells using pH-dependent composite mucoadhesive NPs. Chitosan (CS) and thiolated chitosan (TCS) were used to form the NPs, following by genipin (GP) crosslinking and the surface modification by Eudragit ® L100 (L100). The particle size, morphologies and characteristics of NPs were observed. The α-mangostin loading and release patterns were investigated. In vitro mucoadhesive properties were examined by the wash-off method. In addition, the anti-tumour activity was tested on colorectal cancer cells. The results showed that NPs were slightly oblong in shape with particle size ranging between 300 and 900 nm. The small size of NPs was found with TCS and larger NPs were observed by GP and L100 process. However, GP and L100 provided an increase in α-mangostin loading, limited the release of α-mangostin in the upper gastrointestinal tract, and enhanced α-mangostin delivery to the colon. The TCS-based NPs with GP and L100 exhibited strong mucoadhesion to colon mucosa, more than uncoated-NPs and CS-based NPs. Moreover, NPs exhibited the anti-tumour activity. Therefore, the mucoadhesive TCS-based NPs could be a promising candidate for a controlled-release drug delivery system of α-mangostin to the colon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the same year, colon site-specific mucoadhesive system was developed by Samprasita et al composed of a-Mangostin-loaded thiolated chitosan NPs following by genipin (GP) crosslinking and the surface modification by EudragitVR L100.44”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [44]
Citations
Cites
Evolution of amide bond formation
Joullie, M. M., & Lassen, K. M. (2010) · ARKIVOC · doi:10.3998/ark.5550190.0011.816 · Cited by 182
Flagged first, then by citations
Research works printed but not linked: 48
- 10.1186/1472-6882-12-104 · DOI
- 10.1002/jps.22806 · DOI
- 10.5772/intechopen.71923 · DOI
- 10.1080/03639045.2016.1257020 · DOI
- Chitchumroonchokchai C, 2010, Faseb J, 24, 928
- 10.1002/jps.23795 · DOI
- 10.1080/10611860410001693706 · DOI
- 10.3109/10717544.2015.1089955 · DOI
- Ghazali S, 2010, Int J Chem, 2, 2134
- 10.1016/S0927-7765(99)00156-3 · DOI
- 10.1002/jps.21241 · DOI
- 10.1080/10837450.2020.1832117 · DOI
- 10.1002/app.36548 · DOI
- 10.1016/j.jddst.2020.101801 · DOI
- 10.1038/s41598-017-02008-4 · DOI
- 10.1186/s11671-017-1853-y · DOI
- 10.1016/j.msec.2016.08.011 · DOI
- 10.1016/j.msec.2015.12.085 · DOI
- 10.1039/C9RA10280A · DOI
- 10.1080/10837450.2020.1753771 · DOI
- Kumar R, 2014, Int J Res Pharm Chem, 4, 698
- 10.1016/S0378-5173(02)00638-5 · DOI
- Li P, 2008, Int J Biomed Sci, 4, 221, 10.59566/IJBS.2008.4221 · DOI
- 10.1111/j.2042-7158.1994.tb03854.x · DOI
- 10.3390/ijms11093298 · DOI
- Moghimi SM, 2011, Pharmacol Rev, 53, 283
- 10.1016/j.tet.2005.08.031 · DOI
- 10.1016/j.ijbiomac.2014.08.040 · DOI
- 10.1002/jbm.820290707 · DOI
- 10.1016/S0378-5173(01)00839-0 · DOI
- 10.1002/ptr.2730 · DOI
- 10.2174/0929866521666140807114240 · DOI
- 10.1016/j.fct.2008.07.024 · DOI
- 10.1016/j.ejpb.2013.11.009 · DOI
- 10.1016/j.fitote.2009.06.005 · DOI
- 10.1080/10717540590889781 · DOI
- 10.1016/j.jddst.2018.05.029 · DOI
- 10.1016/j.carbpol.2014.10.026 · DOI
- 10.4103/0975-7406.76478 · DOI
- 10.1021/bm800276d · DOI
- 10.4314/tjpr.v7i3.14694 · DOI
- 10.1021/cg070560a · DOI
- 10.1039/C2SM26928G · DOI
- 10.3748/wjg.v17.i16.2086 · DOI
- 10.2147/DDDT.S273612 · DOI
- 10.1208/s12249-017-0906-y · DOI
- 10.1016/j.addr.2011.02.001 · DOI
- 10.1016/j.carbpol.2015.02.068 · DOI
Cited by
Sorted by citations
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Piotrowska, U., Szatko, J., Nowakowska, A., Klimaszewska, E., Ogorzałek, M., & Sobczak, M. (2025) · Marine Drugs · doi:10.3390/md23120467 · Cited by 14
Metadata
- Authors
- Samprasit, W., Opanasopit, P., & Chamsai, B.
- Venue
- Pharmaceutical Development and Technology
- Publisher
- Informa UK Limited
- Published
- 2021-01-17
- Volume
- 26
- Issue
- 3
- Pages
- 362-372
- ISSN
- 1083-7450
- 1097-9867
- Cited by
- 50
- References
- 1
- Language
- en
- Funders
- Research Institute of Rangsit University
- Thailand Research Funds through the Research Team Promotion Grant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review